2- Year Clinical and Angiographic Outcomes From a Randomized Trial of Polymer-Free Dual Drug-Eluting Stents Versus Polymer-Based Cypher and Endeavor, Drug-Eluting Stents (vol 55, pg 2536, 2010)

被引：1
|
作者：
Byrne, R. A.
Kastrati, A.
Tiroch, K.
机构：
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 56卷 / 03期
关键词：
D O I：
10.1016/j.jacc.2010.06.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [31] A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents The RIBS IV Randomized Clinical Trial
    Alfonso, Fernando
    Perez-Vizcayno, Maria Jose
    Cardenas, Alberto
    del Blanco, Bruno Garcia
    Garcia-Touchard, Arturo
    Lopez-Minguez, Jose Ramon
    Benedicto, Amparo
    Masotti, Monica
    Zueco, Javier
    Iniguez, Andres
    Velazquez, Maite
    Moreno, Raul
    Mainar, Vicente
    Dominguez, Antonio
    Pomar, Francisco
    Melgares, Rafael
    Rivero, Fernando
    Jimenez-Quevedo, Pilar
    Gonzalo, Nieves
    Fernandez, Cristina
    Macaya, Carlos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (01) : 23 - 33
  • [32] The Nine-Month Outcomes of a Polymer-Free Drug-Eluting Stent (YUKON) Compared with Different Polymer Based Drug-Eluting Stents in Real-World Coronary Artery Lesions
    Trajceski, Ted Spase
    Brovina, Lulzim
    Petrovski, Zivko
    Zuna, Blerim
    Petrovski, Borce
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B55 - B55
  • [33] Biodegradable Polymer Versus Permanent Polymer Drug-Eluting Stents and Everolimus- Versus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease 3-Year Outcomes From a Randomized Clinical Trial
    Byrne, Robert A.
    Kastrati, Adnan
    Massberg, Steffen
    Wieczorek, Anna
    Laugwitz, Karl-Ludwig
    Hadamitzky, Martin
    Schulz, Stefanie
    Pache, Juergen
    Fusaro, Massimiliano
    Hausleiter, Joerg
    Schoemig, Albert
    Mehilli, Julinda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (13) : 1325 - 1331
  • [34] Endothelial cell recovery between comparator polymer-based drug-eluting stents
    Joner, Michael
    Nakazawa, Gaku
    Finn, Aloke V.
    Quee, Shawn Chin
    Coleman, Leslie
    Acampado, Eduardo
    Wilson, Patricia S.
    Skorija, Kristi
    Cheng, Qi
    Xu, Xin
    Gold, Herman K.
    Kolodgie, Frank D.
    Virmani, Renu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (05) : 333 - 342
  • [35] A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial (vol 66, pg 23, 2015)
    Alfonso, F.
    Perez-Vizcayno, M. J.
    Cardenas, A.
    del Blanco, Garcia B.
    Garcia-Touchard, A.
    Lopez-Minguez, J. R.
    Benedicto, A.
    Masotti, M.
    Zueco, J.
    Iniguez, A.
    Velazquez, M.
    Moreno, R.
    Mainar, V
    Dominguez, A.
    Pomar, F.
    Melgares, R.
    Rivero, F.
    Jimenez-Quevedo, P.
    Gonzalo, N.
    Fernandez, C.
    Macaya, C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (12) : 1414 - 1414
  • [36] Polymer-free versus durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis
    Wu, James J.
    Way, Joshua A. H.
    Kritharides, Leonard
    Brieger, David
    ANNALS OF MEDICINE AND SURGERY, 2019, 38 : 13 - 21
  • [37] Sustained drug release using cobalt oxide nanowires for the preparation of polymer-free drug-eluting stents
    Bedair, Tarek M.
    Min, Il Jae
    Park, Wooram
    Joung, Yoon Ki
    Han, Dong Keun
    JOURNAL OF BIOMATERIALS APPLICATIONS, 2018, 33 (03) : 352 - 362
  • [38] Polymer-free Versus Biodegradable Polymer Drug-eluting Stents for the Treatment of Coronary Artery Disease: A Meta-analysis of Randomized Trials
    Tan, Sean
    Nogic, Jason
    Thein, Paul
    Nerlekar, Nitesh
    Cameron, James
    Nasis, Arthur
    West, Nick
    Brown, Adam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (16) : S56 - S56
  • [39] Three year clinical outcomes with zotarolimus (Endeavor) drug-eluting stents in an unrestricted contemporary practice
    Giles, Katie
    Hibbert, Benjamin
    Drzymala, Luke
    Armstrong, Marika
    So, Derek
    Le May, Michel R.
    Glover, Christopher
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 595 - 596
  • [40] Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents A systematic review and meta-analysis of 12 randomized controlled trials
    Bundhun, Pravesh Kumar
    Pursun, Manish
    Huang, Feng
    MEDICINE, 2017, 96 (47)
12345